← All news
Markets

Medtronic’s Stars Are Aligning for a Price Recovery

1 source ·1 article ·Sep 1, 11:15 UTC Medtronic

Medtronic beat Q1 FY2027 estimates, raised guidance, and holds a Moderate Buy rating from analysts, with its 3%-plus dividend positioning it near Dividend King status.

Covered by 1 outlet

All coverage · 1 article